S&P 500   3,087.01 (-0.20%)
DOW   27,691.49 (+0.04%)
QQQ   200.96 (-0.13%)
CGC   20.30 (-5.41%)
BABA   186.71 (-0.24%)
GE   11.35 (-1.48%)
T   39.37 (-0.03%)
F   9.08 (+0.44%)
ACB   3.62 (-4.99%)
PRI   129.23 (-0.37%)
BAC   33.18 (-0.24%)
DIS   136.74 (-0.88%)
S&P 500   3,087.01 (-0.20%)
DOW   27,691.49 (+0.04%)
QQQ   200.96 (-0.13%)
CGC   20.30 (-5.41%)
BABA   186.71 (-0.24%)
GE   11.35 (-1.48%)
T   39.37 (-0.03%)
F   9.08 (+0.44%)
ACB   3.62 (-4.99%)
PRI   129.23 (-0.37%)
BAC   33.18 (-0.24%)
DIS   136.74 (-0.88%)
Log in

Frequency Therapeutics Stock Price, Forecast & Analysis (NASDAQ:FREQ)

-0.12 (-0.79 %)
(As of 11/11/2019 04:00 PM ET)
Today's Range
Now: $15.08
50-Day Range N/A
52-Week Range
Now: $15.08
Volume121,946 shs
Average Volume120,683 shs
Market Capitalization$459.25 million
P/E RatioN/A
Dividend YieldN/A
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on harnessing the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its Progenitor Cell Activation approach, uses combinations of small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which has completed a phase I/II clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. Frequency Therapeutics, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:FREQ



Sales & Book Value

Annual SalesN/A



Market Cap$459.25 million
Next Earnings DateN/A
OptionableNot Optionable

Receive FREQ News and Ratings via Email

Sign-up to receive the latest news and ratings for FREQ and its competitors with MarketBeat's FREE daily newsletter.

Frequency Therapeutics (NASDAQ:FREQ) Frequently Asked Questions

What is Frequency Therapeutics' stock symbol?

Frequency Therapeutics trades on the NASDAQ under the ticker symbol "FREQ."

What price target have analysts set for FREQ?

3 equities research analysts have issued 1 year price targets for Frequency Therapeutics' shares. Their forecasts range from $25.00 to $30.00. On average, they anticipate Frequency Therapeutics' share price to reach $27.50 in the next year. This suggests a possible upside of 82.4% from the stock's current price. View Analyst Price Targets for Frequency Therapeutics.

What is the consensus analysts' recommendation for Frequency Therapeutics?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Frequency Therapeutics in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Frequency Therapeutics.

Has Frequency Therapeutics been receiving favorable news coverage?

Media coverage about FREQ stock has trended very negative recently, InfoTrie Sentiment reports. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Frequency Therapeutics earned a news sentiment score of -3.2 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for Frequency Therapeutics.

Who are some of Frequency Therapeutics' key competitors?

What other stocks do shareholders of Frequency Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Frequency Therapeutics investors own include Amarin (AMRN), Chiasma (CHMA), Cronos Group (CRON), Gilead Sciences (GILD), Immunomedics (IMMU), Inseego (INSG), Opko Health (OPK), Selecta Biosciences (SELB), Seagate Technology (STX) and New Residential Investment (NRZ).

Who are Frequency Therapeutics' key executives?

Frequency Therapeutics' management team includes the folowing people:
  • Mr. Marc A. Cohen, Exec. Chairman (Age 56)
  • Mr. David L. Lucchino, Co-­Founder, CEO, Pres, Treasurer, Sec. & Director (Age 50)
  • Dr. Christopher R. Loose, Co­- Founder & Chief Scientific Officer (Age 39)
  • Mr. Will McLean, Co-­Founder and VP of Biology & Regenerative Medicine
  • Mr. Richard J. Mitrano, VP of Fin. & Operations (Age 49)

When did Frequency Therapeutics IPO?

(FREQ) raised $102 million in an initial public offering on Thursday, October 3rd 2019. The company issued 6,700,000 shares at a price of $14.50-$16.00 per share. J.P. Morgan, Goldman Sachs and Cowen served as the underwriters for the IPO and Mizuho Securities was co-manager.

When does Frequency Therapeutics' lock-up period expire?

Frequency Therapeutics' lock-up period expires on Tuesday, March 31st. Frequency Therapeutics had issued 6,000,000 shares in its IPO on October 3rd. The total size of the offering was $84,000,000 based on an initial share price of $14.00. After the end of Frequency Therapeutics' lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

How do I buy shares of Frequency Therapeutics?

Shares of FREQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Frequency Therapeutics' stock price today?

One share of FREQ stock can currently be purchased for approximately $15.08.

How big of a company is Frequency Therapeutics?

Frequency Therapeutics has a market capitalization of $459.25 million. Frequency Therapeutics employs 33 workers across the globe.View Additional Information About Frequency Therapeutics.

What is Frequency Therapeutics' official website?

The official website for Frequency Therapeutics is http://www.frequencytx.com/.

How can I contact Frequency Therapeutics?

Frequency Therapeutics' mailing address is 19 PRESIDENTIAL WAY SUITE 203, WOBURN MA, 01801. The company can be reached via phone at 781-315-4600 or via email at [email protected]

MarketBeat Community Rating for Frequency Therapeutics (NASDAQ FREQ)

Community Ranking:  3.6 out of 5 (star star star)
Outperform Votes:  8 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  11
MarketBeat's community ratings are surveys of what our community members think about Frequency Therapeutics and other stocks. Vote "Outperform" if you believe FREQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FREQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/11/2019 by MarketBeat.com Staff

Featured Article: Straddles

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel